ENABLE: the first phase 4 observational study for patients with relapsing MS treated with ublituximab in real world clinical settings

Drug Category : Array
Conference Category : Array
Lead Author : Fox E, et. al
Published Date : 07/04/2025
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2025/09/ENABLE.AAN_2025.Poster.Fox-Final.pdf
Download Text :
Popup Confirmation? : 1
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top